True North Advisors, LLC Zoetis Inc. Transaction History

True North Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $5.86 Million - $7.56 Million	-32,294 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $324,430 - $413,775	1,675 Added 5.47%	32,294 $7.88 Million
Q3 2021 Jun 07, 2022	BUY	$189.29 - $209.69 $77,798 - $86,182	411 Added 1.36%	30,619 $5.94 Million
Q2 2021 Jun 07, 2022	BUY	$155.9 - $187.99 $25,879 - $31,206	166 Added 0.55%	30,208 $5.63 Million
Q1 2021 Jun 07, 2022	SELL	$144.0 - $169.39 $1,296 - $1,524	-9 Reduced 0.03%	30,042 $4.73 Million
Q4 2020 May 20, 2022	SELL	$157.07 - $174.35 $26,701 - $29,639	-170 Reduced 0.56%	30,051 $4.97 Million
Q3 2020 May 20, 2022	SELL	$137.1 - $165.37 $4.08 Million - $4.92 Million	-29,779 Reduced 49.63%	30,221 $5 Million
Q2 2020 May 20, 2022	SELL	$111.92 - $142.53 $111 - $142	-1 Reduced -0.0%	60,000 $8.22 Million
Q4 2019 May 12, 2022	BUY	$116.25 - $133.25 $6.98 Million - $8 Million	60,001 New	60,001 $7.94 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True North Advisors, LLC with notifications on news.